Tinea versicolor associated with etanercept therapy

Journal of the American Academy of Dermatology

Volumn 58, Issue 5 SUPPL. 1, 2008, Pages

  Levy, Marla S ^a   Polsky, David ^a   Davidson, Anne ^a   Strober, Bruce E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CICLOPIROX; ETANERCEPT; METHOTREXATE; POTASSIUM HYDROXIDE; SELENIUM SULFIDE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORRELATION ANALYSIS; DRUG WITHDRAWAL; FEMALE; HUMAN; LIVER FUNCTION TEST; MONOTHERAPY; PRIORITY JOURNAL; PSORIASIS VULGARIS; SIDE EFFECT; TINEA VERSICOLOR; TREATMENT DURATION; TREATMENT OUTCOME;

HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; TINEA VERSICOLOR;

EID: 41849125598     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.01.023     Document Type: Article

References (3)

1. Klenk A., Martin A., and Heffernan M. Yeast infections: candidiasis, pityriasis (tinea) versicolor. In: Freedberg I. (Ed). Fitzpatrick's dermatology in general medicine Vol 2 (2003), McGraw-Hill, New York 2016-2018
2. Etanercept [package insert] (2006), Amgen, Thousand Oaks, CA
3. Hannuksela M. Cutaneous rash from the use of medicine for rheumatoid arthritis. Duodecim 122 (2006) 105, 111